Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
2,181 to 2,200 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Antisense Oligonucleotides: Translation from Mouse Models to Human Neurodegenerative Diseases. | Neuron | 2017 | 28641106 | PubTator, text mining | PubMed |
| Gene therapy for spinomuscular atrophy: a biomedical advance, a missed opportunity for more equitable drug pricing. | Gene Ther | 2017 | 28639617 | PubTator, text mining | PubMed |
| A multi-source approach to determine SMA incidence and research ready population. | J Neurol | 2017 | 28634652 | PubTator, text mining | PubMed |
| Antisense Oligonucleotides Promote Exon Inclusion and Correct the Common c.-32-13T>G GAA Splicing Variant in Pompe Disease. | Mol Ther Nucleic Acids | 2017 | 28624228 | PubTator, text mining | PubMed |
| Efficient SMN Rescue following Subcutaneous Tricyclo-DNA Antisense Oligonucleotide Treatment. | Mol Ther Nucleic Acids | 2017 | 28624227 | PubTator, text mining | PubMed |
| LNA/DNA mixmer-based antisense oligonucleotides correct alternative splicing of the SMN2 gene and restore SMN protein expression in type 1 SMA fibroblasts. | Sci Rep | 2017 | 28623256 | PubTator, text mining | PubMed |
| Therapeutic opportunities and challenges of induced pluripotent stem cells-derived motor neurons for treatment of amyotrophic lateral sclerosis and motor neuron disease. | Neural Regen Res | 2017 | 28616022 | PubTator, text mining | PubMed |
| Splice-Switching Therapy for Spinal Muscular Atrophy. | Genes (Basel) | 2017 | 28604635 | PubTator, text mining | PubMed |
| Relationships between long-term observations of motor milestones and genotype analysis results in childhood-onset Japanese spinal muscular atrophy patients. | Brain Dev | 2017 | 28601407 | PubTator, text mining | PubMed |
| Molecular inversion probes equipped with discontinuous rolling cycle amplification for targeting nucleotide variants: Determining SMN1 and SMN2 genes in diagnosis of spinal muscular atrophy. | Anal Chim Acta | 2017 | 28577599 | PubTator, text mining | PubMed |
| Redirecting SR Protein Nuclear Trafficking through an Allosteric Platform. | J Mol Biol | 2017 | 28576472 | PubTator, text mining | PubMed |
| How do SMA-linked mutations of SMN1 lead to structural/functional deficiency of the SMA protein? | PLoS One | 2017 | 28570645 | PubTator, text mining | PubMed |
| Therapeutic approaches for spinal muscular atrophy (SMA). | Gene Ther | 2017 | 28561813 | PubTator, text mining | PubMed |
| Developmental regulation of SMN expression: pathophysiological implications and perspectives for therapy development in spinal muscular atrophy. | Gene Ther | 2017 | 28556834 | PubTator, text mining | PubMed |
| A birth of bipartite exon by intragenic deletion. | Mol Genet Genomic Med | 2017 | 28546999 | PubTator, text mining | PubMed |
| [Possible treatments for infantile spinal atrophy]. | Rev Neurol | 2017 | 28524214 | PubTator, text mining | PubMed |
| Genetic screening of spinal muscular atrophy using a real-time modified COP-PCR technique with dried blood-spot DNA. | Brain Dev | 2017 | 28522225 | PubTator, text mining | PubMed |
| Why antisense could make sense for neurodegeneration. | J Neurol | 2017 | 28516330 | PubTator, text mining | PubMed |
| Architecture of the human interactome defines protein communities and disease networks. | Nature | 2017 | 28514442 | PubTator, text mining | PubMed |
| Reduced sensory synaptic excitation impairs motor neuron function via Kv2.1 in spinal muscular atrophy. | Nat Neurosci | 2017 | 28504671 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=110